| Key Takeaways Stem cell therapy for female infertility Stem cell therapy for female infertility is an emerging field, with most treatments still in clinical trial phase.PRP (platelet-rich plasma) injections for the ovary and endometrium have the best current clinical evidence.Stem cell ovarian infusion is being studied for poor ovarian reserve, with some promising small-trial results.According to ICMR, no stem cell therapy for infertility has yet received approval as a standard treatment in India.G-CSF (granulocyte-colony stimulating factor) for thin endometrium has reasonable evidence and is used clinically.Women with poor ovarian reserve or recurrent thin endometrium are the primary candidates for these emerging therapies.Any stem cell treatment for fertility should be done only at an ICMR-registered facility under a research protocol. |
| Quick Facts PRP ovarian injection status: Investigational, small trials showing promise G-CSF for endometrium status: Used clinically in some centres Stem cell ovarian infusion status: Experimental, clinical trials ongoing PRP endometrium cost Pune: INR 20,000 to INR 40,000 G-CSF treatment cost Pune: INR 5,000 to INR 15,000 per cycle Regulatory status: No stem cell fertility treatment approved as standard yet |
Regenerative Fertility Treatment Research Status 2025-2026
| Treatment | Target Condition | Evidence Level | Clinical Status | Source |
| PRP ovarian injection | Poor ovarian reserve | Small RCTs, promising | Investigational | PubMed 2023 |
| PRP endometrial infusion | Recurrent thin endometrium | Moderate evidence | Used clinically in some centres | PubMed 2022 |
| G-CSF endometrial infusion | Thin endometrium in IVF | Reasonable evidence | Used at selected centres | ICMR 2024 |
| Stem cell ovarian infusion | Poor ovarian reserve, POI | Very early trials | Research phase only | Industry estimate |
| Ovarian cortex cryopreservation + transplant | Cancer patients | Established technique | Standard for oncofertility | WHO 2022 |
| Mitochondrial replacement (3-parent IVF) | Poor egg quality | Highly experimental | Not permitted in India | Industry estimate |
What Is Stem Cell Therapy for Infertility?
Stem cells are undifferentiated cells capable of becoming various specialised cell types. In the context of female infertility, the theoretical interest is in using stem cells to regenerate damaged ovarian tissue (in poor ovarian reserve) or repair a thin, unresponsive endometrium (the uterine lining). These conditions are currently among the most difficult to treat in reproductive medicine.
Several approaches are being investigated. Autologous stem cell therapy uses the patient’s own cells, typically bone marrow-derived mesenchymal stem cells or peripheral blood stem cells, to target the ovaries or endometrium. Platelet-rich plasma (PRP), derived from the patient’s own blood, is a simpler technique using growth factors to stimulate tissue repair.
PRP for Poor Ovarian Reserve: What the Evidence Shows
Poor ovarian reserve, characterised by low AMH (below 0.5 ng/mL) and low antral follicle count, means few eggs are retrieved per IVF stimulation cycle. For women who want to use their own eggs, improving ovarian reserve is highly desirable.
Several small trials have explored intraovarian PRP injection (where PRP is injected directly into the ovarian cortex during a laparoscopic procedure) for poor ovarian reserve. Some reports show modest improvements in AMH and antral follicle count 1-3 months after injection. However, the evidence comes from small, non-randomised studies. A randomised controlled trial published in PubMed 2023 showed encouraging but not conclusive results. This treatment is not yet standard care.
Women considering intraovarian PRP should understand they are participating in what is effectively an experimental treatment. It should be offered only within a research protocol at an ICMR-registered centre.
PRP and G-CSF for Thin Endometrium: Better Evidence
A thin endometrium (below 7mm on ultrasound at the time of embryo transfer) reduces implantation rates significantly. Recurrent thin endometrium that doesn’t respond to standard oestrogen therapy is a difficult clinical problem that can prevent IVF success despite good quality embryos.
PRP intrauterine infusion (where PRP is placed inside the uterine cavity 48-72 hours before embryo transfer) and G-CSF (granulocyte colony stimulating factor) intrauterine infusion have both been studied for this indication. The evidence for G-CSF is more established. Multiple studies and a Cochrane review suggest it increases endometrial thickness in women who are refractory to standard treatment. G-CSF is used clinically in some Pune fertility centres for this specific indication.
What Women With Poor Ovarian Reserve Should Know
Before pursuing experimental treatments, women with poor ovarian reserve should exhaust the evidence-based options. DHEA supplementation for 3 months has modest evidence for improving ovarian response. CoQ10 (ubiquinol form) is supported by some evidence for improving egg quality. Acupuncture has weak but not zero evidence. Natural cycle IVF maximises the use of available eggs without wasting them on stimulation that produces minimal response.
The harsh reality is that for very low AMH (below 0.3 ng/mL), donor egg IVF remains the treatment with the highest probability of success. The decision to try experimental treatments versus moving to donor eggs is a deeply personal one. Your doctor can help you weigh the evidence honestly.
Stem Cell Fertility Treatment in Pune: Where Things Stand
India has ICMR guidelines that regulate stem cell research and therapy. Offering stem cell treatment for infertility outside of a registered research protocol is not compliant with current guidelines. Any Pune clinic offering stem cell-based fertility treatment should be able to produce documentation of ICMR registration and ethics committee approval for the specific protocol.
Femcare Fertility in Kalyani Nagar, where Dr. Sayali Shitole Chavan practises, takes an evidence-based approach to regenerative fertility treatments. G-CSF for thin endometrium is considered in appropriate cases. Experimental treatments are discussed openly, with transparent information about their investigational status.
Frequently Asked Questions
Q: Is stem cell therapy for fertility available in Pune?
Some clinics in Pune offer PRP-based treatments for the ovary and endometrium. True stem cell therapies remain largely experimental. Any stem cell fertility treatment offered outside a registered research protocol should be questioned. Ask for the clinic’s ethics committee approval documentation before agreeing to any experimental procedure.
Q: Does PRP work for poor ovarian reserve?
The evidence is encouraging but not conclusive. Small studies show modest improvements in AMH and antral follicle count after intraovarian PRP in some women. Larger randomised controlled trials are needed. Women considering PRP should view it as an experimental option with potential benefit and unknown long-term safety profile, not a standard treatment.
Q: What is G-CSF and how is it used for fertility in Pune?
G-CSF (granulocyte colony stimulating factor) is a protein that stimulates the growth of blood cells and has been found to improve endometrial thickness in some women with thin, unresponsive endometrium. It’s given as an intrauterine infusion 2-3 days before embryo transfer. The evidence is moderate and it is used clinically at some Pune centres in specific cases.
Q: Is there any approved stem cell treatment for female infertility in India?
No. As of 2026, no stem cell therapy for female infertility has received regulatory approval as a standard treatment in India. ICMR permits research in this area at registered institutions. Treatment should only be received as part of an approved research protocol, not as a commercial clinical offering.
Q: I have very low AMH. Should I try PRP before considering donor eggs?
This is a genuinely difficult question. PRP may provide a modest benefit in some cases but is not guaranteed to restore fertility. If your AMH is very low (below 0.3 ng/mL) and time is a factor (age above 38), the statistical probability of success with donor egg IVF is significantly higher than with experimental treatments. Discuss the evidence and your priorities honestly with your specialist.
Conclusion
Stem cell therapy for female infertility in Pune represents one of the most exciting but still-unproven frontiers in reproductive medicine. PRP for the endometrium has the best current evidence for clinical use. Intraovarian PRP and true stem cell therapies remain investigational. Women considering these treatments deserve honest, transparent information about where the science actually stands.
Dr. Sayali Shitole Chavan at Femcare Fertility, Kalyani Nagar, stays current with the latest research in regenerative fertility medicine. She provides evidence-based guidance on which emerging treatments may be appropriate for individual patients and which remain experimental.
Dr. Sayali Chavan - Shitole
Dr. Sayali Shitole Best IVF & Fertility Specialist in Pune is a reliable and among the Best IVF Clinic in Pune & IVF Centre in Pune. Dr. Sayali Shitole is equipped with all ultra-modern facilities IVF Clinic/IVF Centre and Test Tube Baby Centre in Pune.